Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Try the elleFA app to help track endometriosis symptoms and treatments.

Official title: Evaluating the Feasibility of elleFA App Implementation

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT06452407 · Data updated 2026-11-12

This project will try a smartphone app called elleFA to help pre-menopausal women with known or suspected endometriosis who are receiving care at the McGill University Health Centre track symptoms and treatments more accurately.

More Endometriosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment20 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedNovember 3, 2026
Trial IDNCT06452407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pre-menopausal women aged 18 or older with known or suspected endometriosis who are undergoing medical management at the McGill University Health Centre and can consent in English or French.

Probably not a fit

Patients who are post-menopausal, actively pregnant, seeking pregnancy, or not receiving care at MUHC (or who do not use a smartphone) are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who are 18 or older, pre-menopausal, and receiving medical management for endometriosis at MUHC will install and use the elleFA smartphone app to log symptoms, treatments, and related events over a defined period. The study will collect data on how often and how well participants use the app, barriers to use, and whether the app improves completeness of symptom and treatment records. Consent and study materials are available in English and French, and investigators will analyze usage patterns and feasibility metrics to inform wider implementation. No investigational medications or procedures are administered as part of this implementation study.

Why it matters

Potential benefit: If successful, the app could improve symptom tracking and patient–provider communication, helping patients and clinicians find better treatments faster.

How similar studies have gone: Mobile health apps for pain and menstrual tracking have shown promise for engagement and symptom logging, but apps specifically designed for endometriosis are largely novel and have limited published evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pre-menopausal women 18 years of age or older with known or suspected endometriosis
* Undergoing medical management of endometriosis at the MUHC
* Able to provide informed consent in French or in English

Exclusion Criteria:

* Menopausal status
* Pregnant or seeking pregnancy

Where it's running

  • McGill University Health Center
    Montreal, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Andrew Zakhari, MD — McGill University Health Centre/Research Institute of the McGill University Health Centre
  • Study coordinator: Andrew Zakhari, MD
  • Email: andrew.zakhari@mcgill.ca
  • Phone: 514-934-1934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.